Lunit Inc. announced that it has received KRW 72,000,000,000 in a round of funding on November 23, 2021. The transaction included participation from new investors HealthQuest Capital for KRW 24,000,000,000, Casdin Capital, LLC, BrightEdge Ventures, a fund managed by American Cancer Society, Inc., Endowment Arm, Tybourne Capital Management (HK) Ltd., NSG Ventures and NAVER Corporation as strategic investor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
53,700 KRW | -0.19% | +5.92% | -34.43% |
Apr. 16 | Lunit Wins Shareholder Approval for Volpara Health Takeover | MT |
Apr. 12 | Volpara Health Technologies Secures Approval for Lunit’s Proposed Takeover | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.43% | 1.12B | |
+3.41% | 32.18B | |
+14.42% | 7.33B | |
+20.38% | 3.83B | |
-14.26% | 3.23B | |
-27.90% | 1.25B | |
+2.01% | 912M | |
-24.21% | 856M | |
-38.47% | 859M | |
-22.63% | 661M |
- Stock Market
- Equities
- A328130 Stock
- News Lunit Inc.
- Lunit Inc. announced that it has received KRW 72 billion in funding from HealthQuest Capital, Casdin Capital, LLC, American Cancer Society, Inc., Endowment Arm, Tybourne Capital Management (HK) Ltd., NSG Ventures, NAVER Corporation